$120.78
+1.69 (+1.41%)
At Close: Jun 11, 2026
Merck exec says company is discussing use of COVID antiviral drug in Ebola response
12:55pm, Monday, 01'st Jun 2026
Merck is in discussions with various global health authorities about making its COVID antiviral pill molnupiravir available as an Ebola treatment to address the widening outbreak in the Democratic
At a median 5-year (60.3 months) planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran autogene in combination with KEYTRUDA demonstrated a 49% reduction in the risk of recurr
This Emerging Risk Is Unlike Anything the Biotech Industry Has Ever Experienced
01:45pm, Sunday, 31'st May 2026
Biotech companies have always licensed programs, but never so many from one region in particular.
Can MRK's New Drugs & Pipeline Aid Long-Term Growth Post Keytruda LOE?
11:11am, Friday, 29'th May 2026
Merck bets on newer drugs, pipeline candidates and M&A deals to offset looming Keytruda patent expiry and drive long-term growth.
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that calderasib (MK-1084), an investigational oral specific KRAS G12C inhibi
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that calderasib (MK-1084), an investigational oral specific KRAS G12C in
VYM vs. SCHD: Which U.S. Dividend ETF Is a Better Buy?
06:00am, Friday, 29'th May 2026
When choosing dividend ETFs, diversification is a top priority.
Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock
10:01am, Thursday, 28'th May 2026
Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock has in store.
Merck to Participate in the Jefferies Global Healthcare Conference
06:45am, Thursday, 28'th May 2026
RAHWAY, N.J.--(BUSINESS WIRE)--Merck to Participate in the Jefferies Global Healthcare Conference.
Merck and Mastercard are seeing real agentic AI results. Both say the plumbing came first.
02:23pm, Wednesday, 27'th May 2026
Merck is using AI agents to cut drug discovery cycles by a third and ship compliant marketing materials up to 80% faster — but VP of Digital Platforms Sean Finnerty says the only reason it's working
Merck chicken bronchitis vaccine approved for use in China
03:10am, Wednesday, 27'th May 2026
Merck said its vaccine against bronchitis in chickens has been approved by the Chinese agriculture ministry for use in the world's largest chicken-rearing country, which is home to over 5
Merck Announces Third-Quarter 2026 Dividend
01:28pm, Tuesday, 26'th May 2026
RAHWAY, N.J.--(BUSINESS WIRE)--Merck Announces Third-Quarter 2026 Dividend.
MRK Stock Gains After CHMP Backs Keytruda Combo for Bladder Cancer
01:26pm, Monday, 25'th May 2026
Merck jumps after CHMP backs Keytruda plus Padcev for certain bladder cancer patients, a combo with the potential to expand treatment options.
3 Dividend Stocks to Hold for the Next 10 Years
01:23pm, Monday, 25'th May 2026
All of them could be "forever" holdings, but the coming decade could prove surprisingly fruitful for each of these outfits.
Healthcare Stocks Are on Fire -- Don't Miss These Opportunities
04:41pm, Friday, 22'nd May 2026
Innovation, regulatory policy, and demographics are driving healthcare stocks higher. Healthcare companies have also posted strong first-quarter results.
Sign In
Buy MRK